The Tricky Business Of Environmental Control
This article was originally published in The Gray Sheet
Executive Summary
From our digital archives: Manufacturers must keep a firm grasp on environmental controls to avoid potentially tough regulatory penalties. “Clearly environmental controls are important, and FDA will and can take major regulatory action when environmental controls aren’t being adhered to,” ex-FDA official Kim Trautman said in September 2011. Communication is cited as an important aspect for firms as they attempt to ensure that facilities meet FDA’s environmental control requirements.
You may also be interested in...
Device Week, 14 January 2021 – FDA Commissioner News; Spotlight On COVID-19 Enforcement Issues
On this week’s podcast we talk about outgoing US FDA chief Stephen Hahn and the role he wants to play beyond 20 January, as an ex-commissioner. We also discuss the US enforcement landscape around COVID-19-related products and how it’s still taking shape.
FDA Issues 5-Point Action Plan For Artificial Intelligence/Machine Learning-Based SaMD
A new guidance document and a promise to hold a public workshop are just two commitments made by the US agency in a 12 January action plan aimed at AI/ML-based software as a medical device.
FDA Announces Recall Of Boston Scientific’s Lotus Edge TAVR System
The US agency announced on 11 January a recall of the Lotus Edge transcatheter aortic valve replacement (TAVR) system – a device that Boston Scientific stopped making and voluntarily recalled two months ago.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: